Skip to content
Subscriber Only

Former Sanofi CEO Reinvents Himself With Bertarelli Fund

Updated on

Chris Viehbacher’s ugly ouster from Sanofi hasn’t damped his appetite for drugs and science.

Viehbacher, the former chief executive of France’s largest drugmaker, will run Swiss billionaire Ernesto Bertarelli’s U.S. based Gurnet Point Capital fund, according to a statement. He has also joined the board of the technology transfer company PureTech Health Plc, which raised $171 million in an initial public offering on the London Stock Exchange this month.